Ads
related to: transgender hormone therapy
Search results
Results From The WOW.Com Content Network
Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.
And a major, often misunderstood, offering in that toolkit is hormone therapy, which involves administering hormones — estrogen for transgender women and testosterone for transgender men — to ...
Feminizing hormone therapy, also known as transfeminine hormone therapy, is a form of gender-affirming care and a gender-affirming hormone therapy to change the secondary sex characteristics of transgender people from masculine to feminine.
Emily, who is transgender, was first prescribed hormone replacement therapy two years ago. It had enabled her life to feel “ordinary”. Suddenly her prescription had been stopped.
Hormone replacement therapy (HRT) is primarily concerned with alleviating gender dysphoria in transgender people. [17] Hormone therapy targets the secondary sex characteristics. Trans women typically use feminizing therapy, the goal of which is to develop female characteristics while suppressing male characteristics.
In a friend-of-the-court brief, California Atty. Gen. Rob Bonta argued that a "categorical ban" on hormone treatments for transgender teens is bad medical policy and unconstitutionally discriminatory.
Included in the guidelines are sections on purpose and use of the WPATH SOC, the global applicability of the WPATH SOC, the difference between gender nonconformity and gender dysphoria, epidemiology, treatment of children, adolescents and adults, mental health, hormone replacement therapy (masculinizing or feminizing; HRT), reproductive health ...
UCG via GettyTransgender teenagers who begin gender-affirming treatments using puberty blockers are overwhelmingly unlikely to discontinue hormone replacement therapy moving forward, according to ...